DCGI approves Kriya Medical Technologies to manufacture RT-PCR kit

Share Us

608
DCGI approves Kriya Medical Technologies to manufacture RT-PCR kit
15 Feb 2022
4 min read

News Synopsis

DCGI (Drugs Controller General of India), grants its approval to Medical devices firm Kriya Medical Technologies, to manufacture RT-PCR kit that can detect the Omicron variant and its sub-lineages in 45 minutes. Priced at Rs 150 plus taxes, the test is affordable and most suitable for entry point screening at airports, according to the company. Kriya Medical Technologies CEO and Founder Anu Moturi said: "Our focus is to make testing for Covid-19 variants faster, affordable and accessible to everyone, thereby enabling swift prevention and timely treatment. Since KRIVIDA Novus can detect the Omicron variant (B.1.1.529) and all its sub-lineages, such as BA.1, BA.2, and BA.3 in 45 minutes, it is most ideal and beneficial for entry point screening at airports and remobilization of normal conditions in the workplace and institutions”, after acquiring the approval.

TWN In-Focus